⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 15, 2025Open Access

Supplementary Figure S2 from ARID1A Loss plus CD8⁺ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma

Zhaopei Liu Lingkai Zhang Kaifeng Jin Han Zeng Xiaohe Su Yawei Ding Jiaxing Sun Yuzhen Wu Hailong Liu Yu Zhu Le Xu Weijuan Zhang Zewei Wang Yuan Chang Jiejie Xu

View Full Paper

Ask AI

Bookmark

Share

Key Points

Favorable clinical outcomes are linked to ARID1A loss and infiltration of CD8+ T-cells in urothelial carcinoma.
Clinical evaluation demonstrates significant associations with enhanced outcomes in specific patient populations.
IHC images reveal the presence and interaction of ARID1A and CD8+ T-cells in tumor microenvironments.
These findings may help identify potential biomarkers for improving prognosis in urothelial carcinoma patients.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

IHC images show that ARID1A loss and CD8+ T-cell infiltration associate with favorable clinical outcomes in urothelial carcinoma.

Abstract

Representative IHC images of ARID1A and CD8+ T cells in UC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/68f199c5de32064e504dcddb https://doi.org/10.1158/1078-0432.30363430

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from ARID1A Loss plus CD8<sup>+</sup> T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma2025
2Supplementary Figure S4 from ARID1A Loss plus CD8<sup>+</sup> T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma2025
3Data from ARID1A Loss plus CD8<sup>+</sup> T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma2025
4ARID1A loss plus CD8+ T cell infiltration associate with favorable clinical outcomes in urothelial carcinoma.2025 · 1 citations
5Supplementary Figure S1 from ARID1A Loss plus CD8<sup>+</sup> T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma2025